(Q35844072)

10 August 2017

1 reference

title

The role of lymphadenectomy in the surgical management of renal cell carcinoma (English)

1 reference

10 August 2017

1 reference

2

Samir S Taneja

1 reference

10 August 2017

Courtney K Phillips

1

1 reference

10 August 2017

publication date

1 May 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

22

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

214-23; discussion 223-4

1 reference

Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Distant metastasis of renal adenocarcinoma in nephrectomized cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Diagnosis and management of renal cell carcinomaA clinical and pathologic study of 309 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Lymphadenectomy in renal adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

The number of lymph nodes examined and staging accuracy in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Increased incidence of serendipitously discovered renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Occurrence and Localization of Lymph Node Metastases in Renal Carcinoma: A Lymphographic and Histopathological Investigation in Connection with Nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Detection and significance of occult axillary node metastases in patients with invasive breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Renal cell carcinoma: survival and prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

The changing natural history of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

The results of radical nephrectomy for renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Surgery for Metastatic Renal Cell Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Cytoreductive surgery before high dose interleukin-2 based therapy in patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Nephrectomy in metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

The role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Validation of the tumor, nodes and metastasis classification of renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

Renal cell carcinoma as an incidental finding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

inferred from DOI database lookup

7 January 2021

based on heuristic

The natural history of metastatic renal cell carcinoma: a computer analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.028

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLONC.2004.04.028

1 reference

10 August 2017

1 reference